Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
The Oncologist
Published October 13, 2026
Durable Response to Vebreltinib in Heavily Pretreated MET-Amplified Intrahepatic Cholangiocarcino...
October 14, 2026
Medspoke
Medspoke
Leukemia
Published October 12, 2026
00:00
--:--
Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in...
October 13, 2026
Share
Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies.
https://www.medspoke.co/channel_journal?id=683&tap_id=15528
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
American Journal of Hematology
Published October 12, 2026
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy.
October 13, 2026
Why are you reporting this TALK?
